Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-27 @ 10:55 PM
Study NCT ID:
NCT07025460
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-24
First Post:
2025-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study
Sponsor:
Gangnam Severance Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-18
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-09
First Submit QC Date:
None
Study First Post Date:
2025-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-19
Last Update Post Date:
2025-09-24
Last Update Post Date Type:
ESTIMATED